BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24882209)

  • 21. "Trim"ming PolyQ proteins with engineered PML.
    Dhar N; Arsiwala A; Murali S; Kane RS
    Biotechnol Bioeng; 2020 Feb; 117(2):362-371. PubMed ID: 31710088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PML, SUMO, and RNF4: guardians of nuclear protein quality.
    Gärtner A; Muller S
    Mol Cell; 2014 Jul; 55(1):1-3. PubMed ID: 24996060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1.
    Lee S; Hong S; Kang S
    Biochem Biophys Res Commun; 2008 Aug; 372(4):735-40. PubMed ID: 18519031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation.
    Dassouki Z; Sahin U; El Hajj H; Jollivet F; Kfoury Y; Lallemand-Breitenbach V; Hermine O; de Thé H; Bazarbachi A
    Blood; 2015 Jan; 125(3):474-82. PubMed ID: 25395419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp104 is essential for the selective degradation in yeast of polyglutamine expanded ataxin-1 but not most misfolded proteins generally.
    Lee DH; Goldberg AL
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1056-61. PubMed ID: 19995551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
    Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY
    Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
    Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
    Her J; Jeong YY; Chung IK
    FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.
    Orr HT
    Prog Neurobiol; 2012 Dec; 99(3):179-85. PubMed ID: 22531670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.
    Cuchet-Lourenço D; Vanni E; Glass M; Orr A; Everett RD
    J Virol; 2012 Oct; 86(20):11209-22. PubMed ID: 22875967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
    Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
    Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.
    Boutell C; Cuchet-Lourenço D; Vanni E; Orr A; Glass M; McFarlane S; Everett RD
    PLoS Pathog; 2011 Sep; 7(9):e1002245. PubMed ID: 21949651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNF4 promotes tumorigenesis, therapy resistance of cholangiocarcinoma and affects cell cycle by regulating the ubiquitination degradation of p27kip1 in the nucleus.
    Huang J; Yang W; Jiang K; Liu Y; Tan X; Luo J
    Exp Cell Res; 2022 Oct; 419(1):113295. PubMed ID: 35926659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.
    Weisshaar SR; Keusekotten K; Krause A; Horst C; Springer HM; Göttsche K; Dohmen RJ; Praefcke GJ
    FEBS Lett; 2008 Sep; 582(21-22):3174-8. PubMed ID: 18708055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.
    Moran DM; Shen H; Maki CG
    BMC Cell Biol; 2009 May; 10():32. PubMed ID: 19409099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.